HomeBWAY • NASDAQ
add
Brainsway Ltd - ADR
Previous close
$16.71
Day range
$15.91 - $16.56
Year range
$7.84 - $17.92
Market cap
310.55M USD
Avg Volume
59.48K
P/E ratio
31.21
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 12.63M | 26.26% |
Operating expense | 8.92M | 28.34% |
Net income | 2.03M | 237.83% |
Net profit margin | 16.05 | 167.50% |
Earnings per share | 0.05 | — |
EBITDA | 966.00K | 9.28% |
Effective tax rate | 3.34% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.00M | 62.96% |
Total assets | 111.56M | 69.99% |
Total liabilities | 43.43M | 91.74% |
Total equity | 68.13M | — |
Shares outstanding | 37.79M | — |
Price to book | 9.28 | — |
Return on assets | 1.36% | — |
Return on capital | 2.01% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.03M | 237.83% |
Cash from operations | 12.38M | 818.62% |
Cash from investing | -15.86M | -146.37% |
Cash from financing | -264.00K | -654.29% |
Net change in cash | -3.69M | -110.40% |
Free cash flow | 10.01M | 3,078.18% |
About
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
Founded
2003
Headquarters
Website
Employees
120
